Emulsions in health care applications - An overview

Journal of Dispersion Science and Technology

Volumn 23, Issue 1-3, 2002, Pages 419-439

  Marti Mestres, Gilberte ^a   Nielloud, Françoise ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; DRUG PRODUCTS; HEALTH CARE;

DRUG DELIVERY SYSTEMS;

MICROEMULSIONS;

EMULSION; MEDICAL APPLICATION;

EID: 0036066923     PISSN: 01932691     EISSN: None     Source Type: Journal    
DOI: 10.1081/DIS-120003329     Document Type: Article

References (177)

1. Applications of solutol HS 15, a potent solubilizer with a low toxicity
2. Solubility principles and practices for parenteral dosage form development
3. Stealth liposomes
4. Drug release from microparticulate systems
5. Niosomes
6. Nanoparticles
7. Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
8. Ambiosome liposomal amphotericin B: A comparative review
9. Submicron emulsion as colloidal drug carriers for intravenous administration
10. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions
11. Liposome and multiple emulsion formulations augment the anticalcifying efficacy of phosphocitrate in a cutaneous calcergy model
12. Basic study for stabilization of W/O/W/ emulsion and its application to transcatheter arterial embolization theraphy
13. Preparation and evaluation of W/O/W type emulsions containing vancomycin
14. Modulated release of triterpenic compounds from a O/W/O multiple emulsion formulated with dimethicones: Infrared spectrophotometric and differential calometric approaches
15. Enteral absorption of water-in-oil in water insulin emulsions in rabbits
16. On the stability of ascorbic acid in emulsified systems for topical and cosmetic use
17. Evaluation of process parameters involved in chitosan microsphere preparation by the O/W/O multiple emulsion method
18. Biodegradable microspheres: Advance in production technology
19. Insulin in W/O/W multiple emulsions: Preparation characterization and determination of stability towards proteases in vitro
20. Improved stability of W/O/W multiple emulsions by addition of hydrophilic colloid components in the aqueous phases
21. Microemulsion: An overview and pharmaceutical applications
22. Microemulsion-based media as novel drug delivery systems
23. Controlled drug release from macroemulsions, microemulsions, multiple emulsions and gel emulsions
24. Main surfactants used in the pharmaceutical field
25. Bartholow. Parenteral emulsions for drug delivery
26. A novel self emulsifying parenteral drug delivery system
27. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery
28. Preparation of drug-carrier emulsions stabilized with phosphatidylcholine-surfactant mixtures
29. Preparation and properties of a stable intravenous lorazepam emulsion
30. Top ten considerations in the development of parenteral emulsions
31. Parenteral emulsions: Structure, stability, and applications
32. Formulation, stability and toxicity studies of intravenous fat emulsions
33. Physicochemical stability assessments of lipid emulsions of varying oil composition
34. Physicochemical stability of to type of intraveneous lipid emulsion as total nutrient admixtures
35. Submicron emulsions as drug carriers studies on destabilization potential of various drugs
36. Compositional heterogeneity in parenteral lipid emulsions after sedimentation field flow fractionation
37. Emulsion de l'amphotéricine B dans L'intralipide 20% Efficacité in vitro et in vivo
38. The effect of the addition of lignocaine on propofol emulsion stability
39. Naproxen incorporated lipid emulsion, I formulation and stability studies
40. Stability of total parenteral nutrition mixtures as vancomycin and ranitidine delivery systems
41. Side effect evaluation of a new diazepam formulation: Venous sequel reduction following intravenous injection of a diazepam emulsion in rabbit
42. Preparation of lipid emulsion of lorazepam for intravenous injections by ultrasound
43. Efficacy evaluation of a novel submicron miconazole emulsion in marine cryptoccosis model
44. Preparation and evaluation of W/O/W type emulsions containing vancomycin
45. Second-generation perfluorocarbon emulsion blood substitutes
46. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers
47. Perfluorinated blood substitutes and artificial oxygen carriers
48. Current status of artificial oxygen carriers
49. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research
50. Alkoxysilane microemulsion with skin layers for use in drug detoxification
51. Medicated applications
52. Transdermal drug delivery
53. Development of a cream from a self-emulsifying base and moisturizing actives
54. Evaluation of topical drug treatment in psoriasis
55. Microemulsion formed by alkyl polyglucoside and an alkyl glycerol ether with weakly charged films
56. Alkyl polyglycosides, properties and application
57. Using alkyl polyglycosides in personal-care products
58. Solubilization of polar oils with extended surfactants
59. Synthése de dérivés polypropyleneglycol á tête glucyl ou ityl comme surfactif
60. Azone enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis
61. Skin absorption enhancers
62. Permeation enhancers for transdermal drug delivery
63. Screening method for percutaneous absorption enhancers appropraite for adhesive matrix devices
64. LC Analysis of benzophenone-3: II application to determination of 'in vitro' and 'in vivo' skin penetration from solvents, coarse and submicron emulsions
65. Enhanced transdermal delivery of diazepam by submicron emulsion creams
66. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions
67. NMR characterisation and transdermal drug delivery potential of microemulsion systems
68. Submicron emulsion vehicle for enhanced transdermal delivery steroidal and non steroidal antiinflammatory drugs
69. Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics
70. Study of drug availability from O/W emulsions obtained in different manufacturing conditions
71. The effect of rheological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound
72. Use of eutectic mixture of local anesthetics in children
73. Eutectic mixture of local anesthetics reduces pain during intravenous catheter insertion in the pediatric patient
74. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs
75. Effects of microemulsions on the stratum corneum and hydrocortisone penetration
76. Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis
77. Enhanced transdermal delivery of diazepan by submicron emulsion (SME) creams
78. A comparison of the self-emulsifying properties of polyglycosyled glyceride oils
79. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects
80. Intestinal absorption of dolichol from emulsions and liposomes in rat
81. The oral absorption of cefoxitin from oil and emulsion vehicle in rats
82. Self emulsifying drug delivery systems: Assessment of the efficiency of emulsification
83. Theoretical consideration of drug release from submicron oil in water emulsions
84. Micronized emulsion for controlled release of phytostigmine after oral administration. Part II. Release characteristic and pharmacological evaluation
85. Diazepam submicron emulsions containing soya-bean oil and intended for oral or rectal delivery
86. Behaviour of formula emulsions containing hydrolyzed whey protein and various lecithins
87. Gastric emptying-limitind oral absorption of a-linolenic acid administred as a Milk Fat-Globule Membrane (MFGM) emulsion in rats
88. Enhancement of the intestinal absorption of cyclosporine derivative by milk fat globule membrane
89. Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane
90. Administration of emulsions to the gastrointestinal tract
91. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards
92. Emulsions as drug delivery systems
93. Self dispersing lipid formulations for improving oral absorption of lipophilic drugs
94. Enhanced intestinal absorption of cyclosporine in rats through the reduction of droplet size
95. Effects of the physicochemical properties of the emulsion formulation on the bioavailability of ethy-2 chloro-3[4-(2-methy-2-phenylpropyloxy) phenyl]propionate in rats
96. Solubility as a limiting factor to drug absorption
97. Influence of lipolysis on drug absorption from the gastrointestinal tract
98. Inhibition of lipolysis of medium chain triglycerides by nonionic surfactants: A structure activity study
99. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone
100. Charge-dependent interaction of self-emulsifying oil formulations with CaCo-2 cells monolayers: Binding, effects on barrier function and cytotoxicity
101. Emulsions as drug carriers-possibilities, limitations and future perspectives
102. In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsion
103. The effect of oil nature in O/W submicron emulsions on the oral absorption profile of physiostigmine salicylate in rats
104. Systemic bioavailability of penclomedine from oil in water emulsion administered intra duodenally to rats
105. Improved oral delivery of desmopressin via a novel vehicle: Mucoadhesive submicron emulsion
106. Cefpodoxime-proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsions
107. Insulin in W/O/W multiple emulsions: Preparation, characterisation and determination of stability towards proteases in vitro
108. Insulin in W/O/W multiple emulsions: Biological activity after oral administration in normal and diabetic rats
109. Design and evaluation of controlled-release W/O/W multiple emulsion oral liquid delivery system of chlorpheniramine maleate
110. Studies on acyclovir multiple emulsion: Absorption kinetics, bioavailability and hepatic targeting
111. Oral multiple W/O/W emulsion formulation of peptide salmon calcitonin: In vitro and in vivo evaluation
112. Enhanced bioavailability of vancomycin using W/O/W multiple emulsion incorporating highly purified unsaturated fatty acid
113. Lipid microemulsions for improving drug dissolution and oral absorption - Physical and biopharmaceutical aspects
114. Oily formulations for administration to the gastrointestinal tract
115. Administration of emulsions to the gastrointestinal tract
116. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides
117. W/O micro emulsions containing medium-chain fatty acid salts - Formulation and intestinal absorption enhancement evaluation
118. Preparation of micro emulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs
119. Factor VIII responses to oral dDAVP in the dog
120. Microemulsion enhanced absorption of low molecular weight heparin
121. A seven day oral gavage toxicity study of microemulsion formulation in the albino rat
122. The pharmacikinetics of a microemulsion of cyclosporine in primary renal allograft recipients
123. Neoral: A microemulsion cyclosporine
124. Neoral therapy in liver transplantation
125. Neoral the new cyclosporin
126. A new microemulsin formulation of cyclosporin: Pharmacokinetics and clinical features
127. Improving the oral absorption of cyclosporine in malabsorbers: A review of the neoral compassionate need program
128. The use of neoral in rheumatoid arthritis
129. Cyclosporine in ulcerative colitis: State of the art
130. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of microemulsion-based formulation
131. The safety and tolerability of cyclosporin emulsion
132. Microemulsion cyclosporin formulation in contrast to the old formulation
133. Once-a-day oral dosing regimen of cyclosporin A: Combined therapy of cyclosporin premicroemulsion concentrates and enteric coated solid state premicroemulsion concentrates
134. Preparation and in vitro evaluation of self microemulsifying drug delivery systems cont idebenone
135. Enhanced absorption of indomethacin after oral or rectal administration of self-emulsifying system containing indomethacin to rats
136. Self emulsifying drug delivery systems of coenzyme Q10: Formulation development and bioavailability assessement
137. A novel approach to the preparation of injectable emulsions by spontaneous emulsification process
138. Physicochemical characterization and acute toxicity evaluation of a positively charged submicron emulsion vehicle
139. Prevention of topical and ocular oxidative stress by positively charged submicron emulsion
140. The formulation-performance relation ship of multiple emulsions and ocular activity
141. The use of some ingredients for microemulsion preparation containing retinol and its esters
142. Ex vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea
143. Physicochemical properties of chitosan-lipid emulsions and their stability during autoclaving process
144. Influence of the phase volume ratio of multiple emulsions on the ocular activity of prednisolone
145. Improved ocular bioavailability of indomethacin by novel ocular drug carriers
146. Comparative in vitro evaluation of several colloiad systems, nanoparticles, nanocapsules, and nanoemulsions as ocular drug carriers
147. Ocular drug delivery
148. Evaluation of cytotoxicity of various ophtalmic drugs, eye drops excipients and cyclodextrins in an immortalized human corneal epithelial cell line
149. Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle
150. Evaluation of a positively charged submicron emulsion of piroxicam on the rabboit corneum healing process following alkali burn
151. Efficacy and safety of cyclosporine a ophtalmic emulsion in the treatment of moderate-to-severe dry eye disease
152. Evaluation of retinoic acid ophthalmic emulsion in dry eye
153. Ophtalmic emulsions and suspensions
154. Vehicle effect on ocular drug bioavailability II: Evaluation of pilocarpine
155. Vehicle effect on ocular drug bioavailability III: Shear facilitated pilocarpine release from oinment
156. Effect of different oinment bases on ocular anti-inflammatory activity of 4-biphenyl acetic acid in the rabbit
157. Preparation and evaluation of hydrocortisoene multiple emulsions in rabbit's eye
158. Influence of octanoic acid on membrane permeability of timolol from solutions and from microemulsions
159. Microemulsions as topical delivery vehicles: Ocular administration of timolol
160. Poloxamer systems as potential ophthalmics II. Microemulsions
161. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: Effect on intraocular pressure in rabbits
162. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits
163. Preparation and evaluation in vitro of solutions and O/W microemulsions containing levobunolol as ion-pair
164. Amphotericin B eye drops as a lipidic emulsion
165. The stability of piroxicam incorporated in a positively charged submicron emulsion for ocular administration
166. Sequential statistical optimization of a positively charged microemulsion of miconazole
167. Influence of emulsion droplet surface charge on indomethacin ocular tissues distribution
168. Emulsions as drug carriers for ophthalmic use
169. A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits
170. An ophtalmic emulsion of retinoic acid